| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,118 | 26,024 | 28,863 | 29,652 | | Cost of Revenue | 6,855 | 7,572 | 8,047 | 8,836 | | | Gross Profit |
-
| 18,452 | 20,816 | 20,816 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,860 | 29,026 | 14,823 | 17,539 | | Non Recurring | 1,164 | 95,724 | 1,643 | (1,709) | | Others | 2,412 | 22,738 | 11,787 | 8,866 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (129,036) | (7,437) | (3,880) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,827 | (129,036) | (7,437) | (3,880) | | Interest Expense | 962 | 1,097 | 1,102 | 1,861 | | Income Before Tax | 865 | (130,133) | (8,539) | (5,741) | | Income Tax Expense | 79 | (12,217) | (3,261) | (2,249) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 786 | (117,916) | (5,278) | (3,492) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 786 | (117,916) | (5,278) | (3,492) | | Preferred Stock And Other Adjustments | (756) | (761) | (745) | (111) | | | Net Income Applicable To Common Shares | $30 | ($118,677) | ($6,023) | ($3,603) |
|
0.51% Nasdaq 
0.03 (1.06%) 
Income Statement
